Eyeworld

NOV 2018

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: http://digital.eyeworld.org/i/1043093

Contents of this Issue

Navigation

Page 90 of 90

LessDrops, Pred-Gati-Brom, Pred-Brom, Pred-Gati, and ImprimisRx are trademarks of Imprimis Pharmaceuticals, Inc. ©2018 Imprimis Pharmaceuticals, Inc. All Rights Reserved. IMPO0298 7/18 *For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request. 844.446.6979 Order Today: order.imprimisrx.com/Lessdrops Introducing a New For Your Practice Solution PRED-GATI-BROM TM (3.5 ML) Prednisolone acetate, gatifloxacin, bromfenac (1/0.5/0.075%) PRED-GATI-BROM (7 ML) Prednisolone acetate, gatifloxacin, bromfenac (1/0.5/0.075%) PRED-BROM TM (3.5 ML) Prednisolone acetate, bromfenac (1/0.075%) PRED-GATI TM (3.5 ML) Prednisolone acetate, gatifloxacin(1/0.5%) SUSPENSIONS PRED-GATI-BROM TM (3.5 ML) Prednisolone phosphate, gatifloxacin, bromfenac (1/0.5/0.075%) PRED-GATI-BROM (7 ML) Prednisolone phosphate, gatifloxacin, bromfenac (1/0.5/0.075%) PRED-BROM TM (3.5 ML) Prednisolone phosphate, bromfenac (1/0.075%) PRED-GATI TM (3.5 ML) Prednisolone phosphate, gatifloxacin (1/0.5%) SOLUTIONS Expanding the portfolio of combination steroid, antibiotic, and NSAIDs: ® Now offering both solutions and suspensions: The Choice is Yours Proprietary Quality Sterile Compounded Formulations*

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - NOV 2018